News

Published on 6 Nov 2024 on GuruFocus.com · via Yahoo Finance

Syndax Pharmaceuticals Inc (SNDX) Q3 2024 Earnings Call Highlights: Strategic...


Article preview image

Syndax Pharmaceuticals Inc (SNDX) reports robust financials and strategic milestones, including FDA...

NASDAQ.SNDX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Is Syndax Pharmaceuticals, Inc. (SNDX) Among the Best Small-Cap Biotech...

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential Accord...

Insider Monkey · via Yahoo Finance 4 Dec 2024

Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib...

On Tuesday, Syndax Pharmaceuticals Inc (NASDAQ:SNDX) revealed topline results from the relapsed o...

Benzinga · via Yahoo Finance 12 Nov 2024

Syndax Pharmaceuticals Inc (SNDX) Q3 2024 Earnings Call Highlights: Strategic...

Syndax Pharmaceuticals Inc (SNDX) reports robust financials and strategic milestones, including F...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

State Street Corp's Strategic Acquisition in Syndax Pharmaceuticals

Overview of the Recent Trade On September 30, 2024, State Street Corp made a significant addition...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

Syndax Pharmaceuticals Inc (SNDX) Q2 2024 Earnings Call Highlights: Strategic...

With a robust cash position and strategic preparations for upcoming drug launches, Syndax...

GuruFocus.com · via Yahoo Finance 9 Oct 2024

FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease,...

On Wednesday, the FDA approved Incyte Corporation (NASDAQ:INCY) and Syndax Pharmaceuticals Inc’s...

Benzinga · via Yahoo Finance 22 Aug 2024

Syndax Pharmaceuticals, Inc. (SNDX): This Small-Cap Healthcare Stock Is A Good...

We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this articl...

Insider Monkey · via Yahoo Finance 22 Aug 2024

Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA

Syndax Pharmaceuticals SNDX stock rose 7.6% on Mar 27 after it announced a day before that the FD...

Zacks via Yahoo Finance 28 Mar 2024

Zymeworks adds Dr. Neil Gallagher to its board of directors By Investing.com

Dr. Gallagher, with more than two decades of experience in the pharmaceutical and biotechnology...

Investing.com 27 Mar 2024

Syndax Announces FDA Priority Review of NDA for Revumenib for the Treatment of Relapsed/Refractory...

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...

WCMH Columbus 26 Mar 2024